YU44392A - Postupak za dobijanje farmaceutske formulacije diritromicina - Google Patents

Postupak za dobijanje farmaceutske formulacije diritromicina

Info

Publication number
YU44392A
YU44392A YU44392A YU44392A YU44392A YU 44392 A YU44392 A YU 44392A YU 44392 A YU44392 A YU 44392A YU 44392 A YU44392 A YU 44392A YU 44392 A YU44392 A YU 44392A
Authority
YU
Yugoslavia
Prior art keywords
diritromycin
procedure
preparation
pharmaceutical formulation
tablet containing
Prior art date
Application number
YU44392A
Other languages
English (en)
Inventor
J.M. Greene
H.M. Hankins
G.A. Stephenson
D.D. Wirth
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of YU44392A publication Critical patent/YU44392A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)

Abstract

POSTUPAK ZA DOBIJANJE FARMACEUTSKE FORMULACIJE DIRITROMICINA, opisan je postupak za dobijanje tablete koji obuhvata mešanje diritromicina oblik II i jednog ili više farmaceutski prihvatljivih ekscipijenata, kao i oblaganje tablete sa jednim ili više slojeva koji su otporni na žludačne sokove.
YU44392A 1991-04-29 1992-04-24 Postupak za dobijanje farmaceutske formulacije diritromicina YU44392A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
YU44392A true YU44392A (sh) 1994-12-28

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
YU44492A YU44492A (sh) 1991-04-29 1992-04-24 Solvati diritromicina
YU44392A YU44392A (sh) 1991-04-29 1992-04-24 Postupak za dobijanje farmaceutske formulacije diritromicina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU44492A YU44492A (sh) 1991-04-29 1992-04-24 Solvati diritromicina

Country Status (27)

Country Link
EP (2) EP0511800B1 (sh)
JP (2) JP3135672B2 (sh)
KR (2) KR100193742B1 (sh)
CN (2) CN1030611C (sh)
AT (2) ATE138924T1 (sh)
AU (2) AU655978B2 (sh)
BR (2) BR9201540A (sh)
CA (2) CA2067275C (sh)
CY (2) CY1946A (sh)
CZ (2) CZ282021B6 (sh)
DE (2) DE69214710T2 (sh)
DK (2) DK0511800T3 (sh)
ES (2) ES2093779T3 (sh)
FI (2) FI921876A (sh)
GR (2) GR3020439T3 (sh)
HK (2) HK153696A (sh)
HU (2) HU213613B (sh)
IE (2) IE74885B1 (sh)
IL (2) IL101705A (sh)
MX (2) MX9201946A (sh)
MY (2) MY109498A (sh)
NO (2) NO179504C (sh)
NZ (2) NZ242505A (sh)
RU (2) RU2070203C1 (sh)
TW (2) TW216399B (sh)
YU (2) YU44492A (sh)
ZA (2) ZA922776B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (sh) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
ES2173057T3 (es) * 1996-07-29 2004-11-16 Abbott Laboratories Preparacion de la forma ii cristalina de claritromicina.
HUP9904065A3 (en) * 1996-09-24 2001-10-29 Lilly Co Eli Coated particle formulations containing olanzapine
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR100193742B1 (ko) 1999-06-15
FI921876A (fi) 1992-10-30
HU9201398D0 (en) 1992-07-28
IE76296B1 (en) 1997-10-08
NO179504B (no) 1996-07-15
CN1066186A (zh) 1992-11-18
CY1946A (en) 1992-04-27
DE69211220T2 (de) 1996-11-07
HK215096A (en) 1996-12-13
IL101705A0 (en) 1992-12-30
NZ242505A (en) 1993-06-25
YU44492A (sh) 1994-06-24
ATE144425T1 (de) 1996-11-15
MX9201946A (es) 1992-11-01
ATE138924T1 (de) 1996-06-15
MY109498A (en) 1997-02-28
BR9201541A (pt) 1992-12-01
CN1030611C (zh) 1996-01-03
NO180450C (no) 1997-04-23
GR3020439T3 (en) 1996-10-31
KR100194307B1 (ko) 1999-06-15
NO180450B (no) 1997-01-13
JPH05117154A (ja) 1993-05-14
DK0511799T3 (da) 1996-06-24
NO921617L (no) 1992-10-30
CA2067275A1 (en) 1992-10-30
KR920019364A (ko) 1992-11-19
JP3333545B2 (ja) 2002-10-15
NO921616L (no) 1992-10-30
EP0511799A1 (en) 1992-11-04
TW216399B (sh) 1993-11-21
EP0511800A1 (en) 1992-11-04
HU213613B (en) 1997-08-28
AU1525592A (en) 1992-11-05
BR9201540A (pt) 1992-12-01
AU655978B2 (en) 1995-01-19
IL101705A (en) 1996-01-31
RU2045953C1 (ru) 1995-10-20
FI921877A0 (fi) 1992-04-27
FI921876A0 (fi) 1992-04-27
EP0511800B1 (en) 1996-10-23
EP0511799B1 (en) 1996-06-05
AU1525792A (en) 1992-11-05
KR920019365A (ko) 1992-11-19
CS127692A3 (en) 1992-11-18
HUT63956A (en) 1993-11-29
AU646734B2 (en) 1994-03-03
RU2070203C1 (ru) 1996-12-10
IL101704A0 (en) 1992-12-30
MX9201944A (es) 1992-11-01
CZ282218B6 (cs) 1997-06-11
NO921616D0 (no) 1992-04-27
GR3021706T3 (en) 1997-02-28
CA2067274A1 (en) 1992-10-30
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
HK153696A (en) 1996-08-16
DE69211220D1 (de) 1996-07-11
ZA922777B (en) 1993-10-15
HU9203168D0 (en) 1992-12-28
TW315371B (sh) 1997-09-11
ES2093779T3 (es) 1997-01-01
JPH05117289A (ja) 1993-05-14
DK0511800T3 (da) 1997-04-21
HUT62595A (en) 1993-05-28
CS127792A3 (en) 1992-11-18
FI921877A (fi) 1992-10-30
CN1069197C (zh) 2001-08-08
ES2088098T3 (es) 1996-08-01
FI101795B (fi) 1998-08-31
FI101795B1 (fi) 1998-08-31
ZA922776B (en) 1993-10-15
HU215917B (hu) 1999-03-29
IE921345A1 (en) 1992-11-04
IE74885B1 (en) 1997-08-13
IL101704A (en) 1998-02-22
DE69214710T2 (de) 1997-03-13
DE69214710D1 (de) 1996-11-28
CY1975A (en) 1997-09-05
NO921617D0 (no) 1992-04-27
NZ242506A (en) 1993-09-27
IE921346A1 (en) 1992-11-04
CA2067274C (en) 2002-10-15
MY114226A (en) 2002-09-30
NO179504C (no) 1996-10-23
JP3135672B2 (ja) 2001-02-19
CA2067275C (en) 2002-11-26

Similar Documents

Publication Publication Date Title
DK0528734T3 (da) Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
FI934914A (fi) Farmaceutiska formuleringar
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
ITBO910113A1 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
YU44392A (sh) Postupak za dobijanje farmaceutske formulacije diritromicina
SE9003902D0 (sv) Solid dosage forms of a drug
FI942675A0 (fi) Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
DK117291D0 (da) Doseringsform til oral indgift af laegemiddelstoffer
FI941696A (fi) Systeemi lääkkeen oraaliseen antoon